Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103467315A details a green hydrogenation method for p-aminophenol using nano-Ni/Ag, offering high selectivity and industrial scalability for pharma intermediates.
Novel patent CN103319452B enables high-purity synthesis from byproducts ensuring cost reduction and supply chain stability for pharmaceutical intermediates manufacturing globally
Patent CN109293513B reveals a novel metal-mediated route for Sitafloxacin Intermediate II, offering >96% yield and simplified purification for reliable API manufacturing.
Novel 4-step route for Tomivosertib offers high purity and simplified processing for cost-effective API manufacturing and supply chain stability.
Novel patent CN104610129A offers high-yield chiral piperidone synthesis. Enables cost reduction in API manufacturing and ensures supply chain reliability for global partners.
Novel preparation method for almotriptan intermediate eliminates tin residues. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical partners.
Patent CN1914213A reveals a novel protection strategy for thiazolopyrimidines, boosting yields from 40% to 70% and offering significant cost reduction in API manufacturing.
Patent CN108409557A reveals high-purity Brivaracetam intermediate synthesis. This technology offers significant cost reduction and enhanced supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN103755582A details a novel direct resolution of DL-serine using cyclic phosphates. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Novel copper complex patent CN106083902B offers efficient catalytic performance for Henry reactions, ensuring high purity and scalable supply chain solutions for global chemical manufacturers.
Novel patent CN100579967C enables high-purity ornidazole optical antipodes production. Significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel acid-catalyzed synthesis avoids aluminum chloride ensuring high optical purity and scalable production for global pharmaceutical supply chains and cost efficiency.
Patent CN1419557A reveals a novel low-temperature process for fused imidazopyridine derivatives. Discover cost-effective manufacturing and stable crystal forms for API production.
Patent CN114230504B reveals a continuous flow method for pyrrolidone intermediates, enhancing safety and scalability for API manufacturing supply chains.
Patent CN102887872A details an eco-friendly synthesis of Amorolfine HCl using NMP solvent and sodium triacetoxyborohydride, offering high purity and yield for pharmaceutical supply chains.
Patent CN104327149B details a high-yield synthesis route for spironolactone intermediates using 4AD, offering significant supply chain stability and cost advantages.
Patent CN117299207A reveals novel supported catalyst for GalNAc intermediate synthesis offering higher yield and safer scalable production for pharmaceutical supply chains.
Patent CN111302997A reveals a streamlined one-pot method for Raatinib intermediates, offering significant cost and waste reduction for API manufacturing.
Novel patent CN108658956A offers scalable eribulin intermediate synthesis. Reduces steps, enhances purity for reliable pharmaceutical intermediate supply chains.
Patent CN1724554A details a streamlined 5-step synthesis for 1,4-pregnadiene-17α,21-dihydroxy-3,20-dione-17α,21-diacetate, offering high yields and scalable manufacturing for pharmaceutical intermediates.